Tamar Tadmor
Tamar Tadmor
Head of Haematology Unit and Blood Bank in Bnai Zion Medical Center
Verified email at
Cited by
Cited by
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ...
Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ...
Leukemia 32 (8), 1768-1777, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
T Tadmor, Y Zhang, HM Cho, ER Podack, JD Rosenblatt
Cancer Immunology, Immunotherapy 60, 609-619, 2011
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
YC Cohen, M Zada, SY Wang, C Bornstein, E David, A Moshe, B Li, ...
Nature medicine 27 (3), 491-503, 2021
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options
A Aviv, T Tadmor, A Polliack
Annals of oncology 24 (9), 2236-2244, 2013
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
Y Herishanu, G Rahav, S Levi, A Braester, G Itchaki, O Bairey, N Dally, ...
Blood, The Journal of the American Society of Hematology 139 (5), 678-685, 2022
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
T Tadmor, A Aviv, A Polliack
Annals of Oncology 22 (2), 250-256, 2011
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
O Benjamini, L Rokach, G Itchaki, A Braester, L Shvidel, N Goldschmidt, ...
Haematologica 107 (3), 625, 2022
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post …
T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ...
haematologica 99 (1), 125, 2014
Absolute monocytosis at diagnosis correlates with survival in diffuse large B‐cell lymphoma—possible link with monocytic myeloid‐derived suppressor cells
T Tadmor, R Fell, A Polliack, D Attias
Hematological oncology 31 (2), 65-71, 2013
CD30: an important new target in hematologic malignancies
YE Deutsch, T Tadmor, ER Podack, JD Rosenblatt
Leukemia & lymphoma 52 (9), 1641-1654, 2011
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion
Y Zhang, Y Eliav, S Shin, TH Schreiber, ER Podack, T Tadmor, ...
Cancer Immunology, Immunotherapy 62, 87-99, 2013
First-line venetoclax combinations in chronic lymphocytic leukemia
B Eichhorst, CU Niemann, AP Kater, M Fürstenau, J Von Tresckow, ...
New England Journal of Medicine 388 (19), 1739-1754, 2023
The expression of lysyl‐oxidase gene family members in myeloproliferative neoplasms
T Tadmor, J Bejar, D Attias, E Mischenko, E Sabo, G Neufeld, Z Vadasz
American journal of hematology 88 (5), 355-358, 2013
Myeloid‐derived suppressor cells–their role in haemato‐oncological malignancies and other cancers and possible implications for therapy
T Tadmor, D Attias, A Polliack
British journal of haematology 153 (5), 557-567, 2011
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ...
Leukemia 35 (12), 3444-3454, 2021
Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
D Merkel, K Filanovsky, A Gafter‐Gvili, L Vidal, A Aviv, ME Gatt, ...
American journal of hematology 88 (2), 130-134, 2013
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy
K Jamroziak, T Tadmor, T Robak, A Polliack
Leukemia & lymphoma 56 (7), 1949-1958, 2015
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: an observational study
R Ruchlemer, R Ben‐Ami, M Bar‐Meir, JR Brown, M Malphettes, R Mous, ...
Mycoses 62 (12), 1140-1147, 2019
The system can't perform the operation now. Try again later.
Articles 1–20